Nyrada
Menu
NYR:
Market Cap*:
Price Delay ~20min
Home
About Us
Company Overview
Board of Directors
Senior Management
Scientific Advisory Board
Corporate Governance
Programs
Xolatryp
Myocardial Ischemia and Arrhythmia Control
Stroke
Traumatic Brain Injury
Investors
Investor Welcome
Company Fact Sheet
ASX Announcements
Financial Reports
Corporate Announcements
Investor Presentations
Share Price Information
Investors Glossary
Annual Reports
Analyst Reports
Annual General Meeting
Extraordinary General Meeting
Past General Meetings
News & Insights
Presentations & Interviews
Media
Newsletters
Publications
Contact Us
Contact Us
Working at Nyrada
Email Alerts
Investors
Home
>
Investors
>
ASX Announcements
Investor Welcome
Company Fact Sheet
ASX Announcements
Financial Reports
Corporate Announcements
Investor Presentations
Share Price Information
Investors Glossary
Annual Reports
Analyst Reports
Annual General Meeting
Extraordinary General Meeting
Past General Meetings
ASX Announcements
Filter by Year:
2025
2024
2023
2022
2021
2020
5-Sep-2022
Presentation to E&P Small Caps Health Care Conference
29-Aug-2022
Nyrada Reports Full Year FY2022 Results
29-Aug-2022
Annual Report to June 30 2022
29-Aug-2022
Preliminary Final Report
29-Aug-2022
Appendix 4G and Corporate Governance Statement
2-Aug-2022
Nyrada Board Changes
2-Aug-2022
Initial Director's Interest Notice - GM
2-Aug-2022
Final Director's Interest Notice - PM
26-Jul-2022
Quarterly Activities Report and Appendix 4C
20-Jul-2022
Nyrada PCSK9 Inhibitor Tested in Model of Atherosclerosis
Previous
1
2
3
4
Next
